We are developing a rapid, simple-to-use, ultrasensitive diagnostics platform for high-value biomolecules.  The company has built a benchtop instrument for the biomedical research market and is rapidly moving towards a point-of-care device.  The instrument, powered by quantum sensor technology invented at Harvard, is currently generating data for a number of leading laboratories in academia and industry.

Current immunoassay diagnostics generally rely on optical detection technologies. Our imaging platform – using magnetic rather than optical tags – enables an extremely simple, reliable, and high-performance single-molecule detection capability. This magnetic detection approach is simpler, cheaper, and highly flexible, allowing fast, quantitative analysis of biomarkers (proteins, nucleic acids, or cells) with applications in key areas such as neurology, immuno-oncology, and infectious disease.